Instant, free access to essential Thomson Reuters reports and presentations, drawing on resources such as Thomson Pharma, Thomson Message Mapping System, CMR International, and Derwent World Patent Index.
Expand your knowledge with key reports from industry experts
- Establishing the Standards in Biomarker Research - Discover biomarkers potential to encourage innovation, improve efficiency, and gain research organizations an advantage over their competitors.
- 10 Ways…to Influence the MarketPDF- Influence the market positively and make sure you realize the greatest possible return on your investment.
- Global R&D expenditure, development times, global pharmaceutical sales and new molecular entity output 1997-2007
- Development time for new molecular entities first launched onto the world market between 1997 - 2007
- Proportional change of enrolled patients in each geographical region between 2000 and 2006 (Clinical)
- Number of pharmaceutical patent applications and granted patents for 5 major patent issuing authorities 1997-2007 (Patents)
- Analysis of messaging in the media - Top ten audiences targeted by therapy area (Marketing & Messagies)
- Analysis of messaging in the media - Top 10 Drugs Based on Credibility Index in the Literature (Marketing & Messages)
- Analysis of messaging in the media - Top 10 Source Types (Marketing & Messages)
Enhance your presentations and reports with clearly presented information on historical trends in the pharmaceutical industry
- Clinical: A deeper looks at look some key geographic and enrolment trends affecting clinical development timelines globally.
- Development Pipeline: The analysis represented in this area looks at trends from a number of angles including mode of actions, therapy area, stage of development, and R&D expenditure.
- Generics: An examination of global generics opportunities and launch trends as well as taking a look at effects on the growth and development of the generic industry such as patent challenges and the API supply.
- Marketing & Messages: Results displayed here look at key commercial trends such as revenues by therapy area and company size as well as the impact messages published in journal articles, abstracts, monographs, posters…have on the attitudes and treatment habits of prescribing clinicians.
- Patents: A slide representation of the analysis of key data sources related to patent activity such as the number of pharmaceutical patent applications and granted patents from the five major patent issuing authorities
- R&D Expenditure: The analysis represented in this area looks at trends from a number of angles.
- Regulatory: Analysis of some key geographic trends as well as some trends related to submission and market approval times and data on the number of NAS and NME launches.
The Ones to Watch
Promising new treatments for cancer and hepatitis C are moving through the pipelines. Discover the five most promising drugs from Phase I, II, IIIto approval this quarter.
Who's Making the Biggest Splash?
Novartis, AstraZeneca and Pfizer had the biggest impact in medical research this quarter. See where the top 15 companies are ranked for their messaging.